<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37631968</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1625</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15081625</ELocationID><Abstract><AbstractText>It is known that SARS-CoV-2 infection can result in gastrointestinal symptoms. For some, these symptoms may persist beyond acute infection, in what is known as 'post-COVID syndrome'. We conducted a systematic review to examine the prevalence of persistent gastrointestinal symptoms and the incidence of new gastrointestinal illnesses following acute SARS-CoV-2 infection. We searched the scientific literature using MedLine, SCOPUS, Europe PubMed Central and medRxiv from December 2019 to July 2023. Two reviewers independently identified 45 eligible articles, which followed participants for various gastrointestinal outcomes after acute SARS-CoV-2 infection. The study quality was assessed using the Joanna Briggs Institute Critical Appraisal Tools. The weighted pooled prevalence for persistent gastrointestinal symptoms of any nature and duration was 10.8% compared with 4.9% in healthy controls. For seven studies at low risk of methodological bias, the symptom prevalence ranged from 0.2% to 24.1%, with a median follow-up time of 18 weeks. We also identified a higher risk for future illnesses such as irritable bowel syndrome, dyspepsia, hepatic and biliary disease, liver disease and autoimmune-mediated illnesses such as inflammatory bowel disease and coeliac disease in historically SARS-CoV-2-exposed individuals. Our review has shown that, from a limited pool of mostly low-quality studies, previous SARS-CoV-2 exposure may be associated with ongoing gastrointestinal symptoms and the development of functional gastrointestinal illness. Furthermore, we show the need for high-quality research to better understand the SARS-CoV-2 association with gastrointestinal illness, particularly as population exposure to enteric infections returns to pre-COVID-19-restriction levels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hawkings</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Public Health, Policy &amp; Systems, Institute of Population Health, University of Liverpool, Liverpool L69 3GF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaselli</LastName><ForeName>Natasha Marcella</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0003-0220-9249</Identifier><AffiliationInfo><Affiliation>National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary &amp; Ecological Sciences, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charalampopoulos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Public Health, Policy &amp; Systems, Institute of Population Health, University of Liverpool, Liverpool L69 3GF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brierley</LastName><ForeName>Liam</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3026-4723</Identifier><AffiliationInfo><Affiliation>Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool L69 3GF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elliot</LastName><ForeName>Alex J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Real-Time Syndromic Surveillance Team, Field Services, Health Protection Operations, UK Health Security Agency, Birmingham B2 4BH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchan</LastName><ForeName>Iain</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3392-1650</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Policy &amp; Systems, Institute of Population Health, University of Liverpool, Liverpool L69 3GF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hungerford</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9770-0163</Identifier><AffiliationInfo><Affiliation>National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary &amp; Ecological Sciences, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PDF-2018-11-ST2-006</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR-200910</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diarrhoea</Keyword><Keyword MajorTopicYN="N">gastrointestinal</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37631968</ArticleId><ArticleId IdType="pmc">PMC10459193</ArticleId><ArticleId IdType="doi">10.3390/v15081625</ArticleId><ArticleId IdType="pii">v15081625</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 18 July 2023)].  Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence  Overview|COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19|Guidance|NICE.  [(accessed on 11 April 2023)].  Available online:  https://www.nice.org.uk/guidance/NG188.</Citation></Reference><Reference><Citation>Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK&#x2013;Office for National Statistics.  [(accessed on 11 April 2023)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/5january2023.</Citation></Reference><Reference><Citation>Mair M., Singhavi H., Pai A., Singhavi J., Gandhi P., Conboy P., Baker A., Das Frcs S. A Meta-Analysis of 67 Studies with Presenting Symptoms and Laboratory Tests of COVID-19 Patients. Laryngoscope. 2021;131:1254&#x2013;1265. doi: 10.1002/lary.29207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29207</ArticleId><ArticleId IdType="pubmed">33068023</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshazli R.M., Kline A., Elgaml A., Aboutaleb M.H., Salim M.M., Omar M., Munshi R., Mankowski N., Hussein M.H., Attia A.S., et al. Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves. J. Med. Virol. 2021;93:2740&#x2013;2768. doi: 10.1002/jmv.26836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26836</ArticleId><ArticleId IdType="pmc">PMC8014082</ArticleId><ArticleId IdType="pubmed">33527440</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham G., Taegtmeyer M., Lewis J., Subramanian S. Gastrointestinal symptoms involvement in hospitalised COVID-19 patients in Liverpool, UK: A descriptive cross-sectional, single-centre study. Clin. Med. 2021;21((Suppl. S2)):23&#x2013;24. doi: 10.7861/clinmed.21-2-s23.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.21-2-s23</ArticleId><ArticleId IdType="pubmed">34078683</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes E.S., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N., Chowdhury M., Singh A.K., Ma K., Kumar A., Ranjan P., Desai D., Wig N. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov. Ther. 2021;15:156&#x2013;161. doi: 10.5582/ddt.2021.01014.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01014</ArticleId><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H., Mehandru S. Gastrointestinal post-acute COVID-19 syndrome. Nat. Rev. Gastroenterol. Hepatol. 2022;19:345&#x2013;346. doi: 10.1038/s41575-022-00611-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00611-z</ArticleId><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 2020;14:185&#x2013;192. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F., Daniele A., Amato F., Pastore L., Matera M.G., Cazzola M., Castaldo G., Bianco A. ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020;198:867&#x2013;877. doi: 10.1007/s00408-020-00408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00408-4</ArticleId><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T., Perlot T., Rehman A., Trichereau J., Ishiguro H., Paolino M., Sigl V., Hanada T., Hanada R., Lipinski S., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487:477&#x2013;481. doi: 10.1038/nature11228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11228</ArticleId><ArticleId IdType="pmc">PMC7095315</ArticleId><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., Guo F., Zhang X., Luo R., Huang C., et al. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2020;71:2669&#x2013;2678. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Shi X., Fu W., Xiang F., He X., Yang B., Wang X., Ma W.-L. Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever. J. Inflamm. Res. 2021;14:2619&#x2013;2631. doi: 10.2147/JIR.S311518.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S311518</ArticleId><ArticleId IdType="pmc">PMC8217908</ArticleId><ArticleId IdType="pubmed">34168484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain I., Cher G.L.Y., Abid M.B. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential. Front. Immunol. 2021;12:765965. doi: 10.3389/fimmu.2021.765965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.765965</ArticleId><ArticleId IdType="pmc">PMC8551858</ArticleId><ArticleId IdType="pubmed">34721437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Kumari C., Faiq M.A., Pareek V., Narayan R.K. SARS-CoV-2 Infectivity Vis-A-Vis Human Gut and Mesentery: Pathogenic Implications for COVID-19. SSRN Electron. J. 2020;93:1343&#x2013;1350. doi: 10.2139/ssrn.3636978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3636978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Yoon G.Y., Myoung J., Kim S.-J., Ahn D.-G. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Emerg. Microbes Infect. 2020;9:2169&#x2013;2179. doi: 10.1080/22221751.2020.1827985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1827985</ArticleId><ArticleId IdType="pmc">PMC7580600</ArticleId><ArticleId IdType="pubmed">32969768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fikree A., Byrne P. Management of functional gastrointestinal disorders. Clin. Med. 2021;21:44&#x2013;52. doi: 10.7861/clinmed.2020-0980.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0980</ArticleId><ArticleId IdType="pmc">PMC7850201</ArticleId><ArticleId IdType="pubmed">33479067</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballou S., Bedell A., Keefer L. Psychosocial impact of irritable bowel syndrome: A brief review. World. J. Gastrointest. Pathophysiol. 2015;6:120&#x2013;123. doi: 10.4291/wjgp.v6.i4.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.4291/wjgp.v6.i4.120</ArticleId><ArticleId IdType="pmc">PMC4644875</ArticleId><ArticleId IdType="pubmed">26600969</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D., Steptoe A., Bu F. Long-term psychological consequences of long Covid: A propensity score matching analysis comparing trajectories of depression and anxiety symptoms before and after contracting long Covid vs. short Covid. MedRxiv. 2022 doi: 10.1101/2022.04.01.22273305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.01.22273305</ArticleId></ArticleIdList></Reference><Reference><Citation>MigliaMigliavaca C.B., Stein C., Colpani V., Munn Z., Falavigna M. Prevalence Estimates Reviews&#x2013;&#x2013;Systematic Review Methodology Group (PERSyst). Quality assessment of prevalence studies: A systematic review. J. Clin. Epidemiol. 2020;127:59&#x2013;68. doi: 10.1016/j.jclinepi.2020.06.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.06.039</ArticleId><ArticleId IdType="pubmed">32679313</ArticleId></ArticleIdList></Reference><Reference><Citation>Halverson C.C., Bailey C., Ennis J.A., Cox E.E. Nursing surveillance of respiratory adverse events among hospitalized adults: A systematic review to guide evidence-based practice. Worldviews Evid. Based Nurs. 2022;19:260&#x2013;266. doi: 10.1111/wvn.12581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/wvn.12581</ArticleId><ArticleId IdType="pubmed">35638706</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung T., Cheng C.P.W., Fong T.K.H., Sharew N.T., Anders R.L., Xiang Y.T., Lam S.C. Psychological impact on healthcare workers, general population and affected individuals of SARS and COVID-19: A systematic review and meta-analysis. Front. Public Health. 2022;10:1004558. doi: 10.3389/fpubh.2022.1004558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1004558</ArticleId><ArticleId IdType="pmc">PMC9673757</ArticleId><ArticleId IdType="pubmed">36407973</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S., R&#xfc;cker G., Schwarzer G. How to perform a meta-analysis with R: A practical tutorial. Evid. Based Ment. Health. 2019;22:153&#x2013;160. doi: 10.1136/ebmental-2019-300117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.S., Ferdous M.Z., Islam U.S., Mosaddek A.S.M., Potenza M.N., Pardhan S. Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh. Int. J. Environ. Res. Public Health. 2021;18:1453. doi: 10.3390/ijerph18041453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041453</ArticleId><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodeir M.M., Shabana H.A., Rasheed Z., Alkhamiss A.S., Khodeir M., Alkhowailed M.S., Alharbi S., Alsoghair M., Alsagaby S.A., Al Abdulmonem W. COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia. PLoS ONE. 2021;16:e0260259. doi: 10.1371/journal.pone.0260259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260259</ArticleId><ArticleId IdType="pmc">PMC8654233</ArticleId><ArticleId IdType="pubmed">34879074</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar M.A., Martins R.S., Dhillon R.A., Tharwani A., Irfan O., Suriya Q.F., Rizwan W., Khan J.A., Zubairi A.b.S. Residual symptoms and the quality of life in individuals recovered from COVID-19 infection: A survey from Pakistan. Ann. Med. Surg. 2022;75:103361. doi: 10.1016/j.amsu.2022.103361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103361</ArticleId><ArticleId IdType="pmc">PMC8832846</ArticleId><ArticleId IdType="pubmed">35186286</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaillant M.-F., Agier L., Martineau C., Philipponneau M., Romand D., Masdoua V., Behar M., Nesseler C., Achamrah N., Laub&#xe9; V., et al. Food intake and weight loss of surviving inpatients in the course of COVID-19 infection: A longitudinal study of the multicenter NutriCoviD30 cohort. Nutr. Burbank. 2022;93:111433. doi: 10.1016/j.nut.2021.111433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2021.111433</ArticleId><ArticleId IdType="pmc">PMC8314865</ArticleId><ArticleId IdType="pubmed">34482098</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;rard M., Mahmutovic M., Malgras A., Michot N., Scheyer N., Jaussaud R., Nguyen-Thi P.-L., Quilliot D. Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19. Nutrients. 2021;13:3964. doi: 10.3390/nu13113964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113964</ArticleId><ArticleId IdType="pmc">PMC8618979</ArticleId><ArticleId IdType="pubmed">34836219</ArticleId></ArticleIdList></Reference><Reference><Citation>Damanti S., Cilla M., Cilona M., Fici A., Merolla A., Pacioni G., De Lorenzo R., Martinenghi S., Vitali G., Magnaghi C., et al. Prevalence of Long COVID-19 Symptoms After Hospital Discharge in Frail and Robust Patients. Front. Med. 2022;9:834887. doi: 10.3389/fmed.2022.834887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.834887</ArticleId><ArticleId IdType="pmc">PMC9329529</ArticleId><ArticleId IdType="pubmed">35911387</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., G&#xfc;neri F.D., Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: Prospective follow-up by phone interviews. Rheumatol. Int. 2021;41:1263&#x2013;1271. doi: 10.1007/s00296-021-04882-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04882-8</ArticleId><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkacemi M., Baouche H., Gomis S., Lassalle M., Couchoud C., Registry T.R. Long-lasting clinical symptoms 6 months after COVID-19 infection in the French national cohort of patients on dialysis. J. Nephrol. 2022;35:787&#x2013;793. doi: 10.1007/s40620-022-01295-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-022-01295-z</ArticleId><ArticleId IdType="pmc">PMC8924724</ArticleId><ArticleId IdType="pubmed">35294748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Ailshire J.A., Crimmins E.M. Long COVID and symptom trajectory in a representative sample of Americans in the first year of the pandemic. Sci. Rep. 2022;12:11647. doi: 10.1038/s41598-022-15727-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15727-0</ArticleId><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Faycal A., Ndoadoumgue A., Sellem B., Blanc C., Dudoit Y., Schneider L., Tubiana R., Valantin M.-A., Seang S., Palich R., et al. Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients. Infect. Dis. Now. 2022;52:75&#x2013;81. doi: 10.1016/j.idnow.2021.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2021.11.003</ArticleId><ArticleId IdType="pmc">PMC8596656</ArticleId><ArticleId IdType="pubmed">34800742</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau O., Wiernik E., Lemogne C., de Lamballerie X., Ninove L., Blanch&#xe9; H., Deleuze J.-F., Ribet C., Kab S., Goldberg M., et al. Persistent symptoms after the first wave of COVID-19 in relation to SARS-CoV-2 serology and experience of acute symptoms: A nested survey in a population-based cohort. Lancet Reg. Health Eur. 2022;17:100363. doi: 10.1016/j.lanepe.2022.100363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100363</ArticleId><ArticleId IdType="pmc">PMC9005155</ArticleId><ArticleId IdType="pubmed">35434687</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L., Yang B., Jiang N., Fu W., He X., Zhou Y., Ma W.-L., Wang X. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J. Korean Med. Sci. 2020;35:e418. doi: 10.3346/jkms.2020.35.e418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e418</ArticleId><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Sheng L., Han C., Jin Y., Bai T., Lin R., Ding Z., Hou X. Features of capsule endoscopy in COVID-19 patients with a six-month follow-up: A prospective observational study. J. Med. Virol. 2022;94:246&#x2013;252. doi: 10.1002/jmv.27308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27308</ArticleId><ArticleId IdType="pmc">PMC8662114</ArticleId><ArticleId IdType="pubmed">34460118</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J., Abdel-Mannan O., Grant K., Maillard S., Kucera F., Hassell J., Eyre M., Berger Z., Hacohen Y., Moshal K., et al. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: A retrospective cohort study. Lancet Child. Adolesc. Health. 2021;5:473&#x2013;482. doi: 10.1016/S2352-4642(21)00138-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00138-3</ArticleId><ArticleId IdType="pubmed">34043958</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepan M.D., Cioboata R., Vintilescu B., Vasile C.M., Osman A., Ciolofan M.S., Popescu M., Petrovici I.L., Zavate A.C. Pediatric Functional Abdominal Pain Disorders following COVID-19. Life. 2022;12:509. doi: 10.3390/life12040509.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12040509</ArticleId><ArticleId IdType="pmc">PMC9027938</ArticleId><ArticleId IdType="pubmed">35455000</ArticleId></ArticleIdList></Reference><Reference><Citation>Comelli A., Viero G., Bettini G., Nobili A., Tettamanti M., Galbussera A.A., Muscatello A., Mantero M., Canetta C., Boneschi F.M., et al. Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study. Front. Med. 2022;9:834354. doi: 10.3389/fmed.2022.834354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.834354</ArticleId><ArticleId IdType="pmc">PMC8981315</ArticleId><ArticleId IdType="pubmed">35391879</ArticleId></ArticleIdList></Reference><Reference><Citation>Attauabi M., Dahlerup J.F., Poulsen A., Hansen M.R., Vester-Andersen M.K., Eraslan S., Prahm A.P., Pedersen N., Larsen L., Jess T., et al. Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases&#x2013;A Danish Prospective Population-Based Cohort Study with Individual-Level Data. J. Crohns Colitis. 2021;16:jjab192. doi: 10.1093/ecco-jcc/jjab192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjab192</ArticleId><ArticleId IdType="pmc">PMC8689957</ArticleId><ArticleId IdType="pubmed">34755858</ArticleId></ArticleIdList></Reference><Reference><Citation>Liptak P., Duricek M., Rosolanka R., Ziacikova I., Kocan I., Uhrik P., Grendar M., Hrnciarova M., Bucova P., Galo D., et al. Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: A prospective, observational study. Eur. J. Gastroenterol. Hepatol. 2022;34:925. doi: 10.1097/MEG.0000000000002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000002425</ArticleId><ArticleId IdType="pubmed">35913778</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Di Cristanziano V., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Noviello D., Costantino A., Muscatello A., Bandera A., Consonni D., Vecchi M., Basilisco G. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study. Neurogastroenterol. Motil. 2022;34:e14187. doi: 10.1111/nmo.14187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14187</ArticleId><ArticleId IdType="pmc">PMC8209890</ArticleId><ArticleId IdType="pubmed">34060710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal U.C., Ghoshal U., Rahman M.M., Mathur A., Rai S., Akhter M., Mostafa T., Islam M.S., Haque S.A., Pandey A., et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case&#x2013;control study. J. Gastroenterol. Hepatol. 2022;37:489&#x2013;498. doi: 10.1111/jgh.15717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15717</ArticleId><ArticleId IdType="pmc">PMC8657345</ArticleId><ArticleId IdType="pubmed">34672022</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Tejada C.E., Herrera-Garc&#xed;a C.F., Godina-Gonz&#xe1;lez S., Villagrana-Ba&#xf1;uelos K.E., Amaro J.D.D.L., Herrera-Garc&#xed;a K., Rodr&#xed;guez-Qui&#xf1;ones C., Zanella-Calzada L.A., Ram&#xed;rez-Barranco J., de Avila J.L.R., et al. Persistence of COVID-19 Symptoms after Recovery in Mexican Population. Int. J. Environ. Res. Public Health. 2020;17:9367. doi: 10.3390/ijerph17249367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249367</ArticleId><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;A nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Plata R., Higuera-Iglesias A.-L., Torres-Esp&#xed;ndola L.M., Aquino-G&#xe1;lvez A., Cruz R.V., Camarena A., Alderete J.C., Garc&#xed;a J.R., Alvarado-V&#xe1;squez N., Brise&#xf1;o D.M., et al. Risk of Pulmonary Fibrosis and Persistent Symptoms Post-COVID-19 in a Cohort of Outpatient Health Workers. Viruses. 2022;14:1843. doi: 10.3390/v14091843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091843</ArticleId><ArticleId IdType="pmc">PMC9504101</ArticleId><ArticleId IdType="pubmed">36146648</ArticleId></ArticleIdList></Reference><Reference><Citation>Austhof E., Bell M.L., Riddle M.S., Catalfamo C., McFadden C., Cooper K., Walter E.S., Jacobs E., Pogreba-Brown K. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: Results from the Arizona CoVHORT. Epidemiol. Infect. 2022;150:e136. doi: 10.1017/S0950268822001200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268822001200</ArticleId><ArticleId IdType="pmc">PMC9343359</ArticleId><ArticleId IdType="pubmed">35801302</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler L., Israel M., Yehoshua I., Azuri J., Hoffman R., Shahar A., Reuveni M.M., Grossman Z. Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: A cross-sectional study. BMJ Open. 2023;13:e064155. doi: 10.1136/bmjopen-2022-064155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-064155</ArticleId><ArticleId IdType="pmc">PMC9944622</ArticleId><ArticleId IdType="pubmed">36810170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin Ahn B., Choi S.H., Yun K.W. Non-neuropsychiatric Long COVID Symptoms in Children Visiting a Pediatric Infectious Disease Clinic After an Omicron Surge. Pediatr. Infect. Dis. J. 2023;42:e143. doi: 10.1097/INF.0000000000003862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003862</ArticleId><ArticleId IdType="pmc">PMC10097469</ArticleId><ArticleId IdType="pubmed">36795575</ArticleId></ArticleIdList></Reference><Reference><Citation>Chancharoenthana W., Kamolratanakul S., Leelahavanichkul A., Ariyanon W., Chinpraditsuk S., Saelim R., Vadcharavivad S., Phumratanaprapin W., Wilairatana P. Gastrointestinal manifestations of long-term effects after COVID-19 infection in patients with dialysis or kidney transplantation: An observational cohort study. World. J. Gastroenterol. 2023;29:3013&#x2013;3026. doi: 10.3748/wjg.v29.i19.3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v29.i19.3013</ArticleId><ArticleId IdType="pmc">PMC10237091</ArticleId><ArticleId IdType="pubmed">37274795</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa e Silva G.R., Moura Winny &#xc9;.A., dos Santos K.C., Gomes D.O., Bandeira G.N., Guimar&#xe3;es R.A., Rosso C.F.W., Bazilio G.S., Leite V.R.M.C., Caetano K.A.A., et al. Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study. Int. J. Environ. Res. Public Health. 2023;20:1483. doi: 10.3390/ijerph20021483.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021483</ArticleId><ArticleId IdType="pmc">PMC9865648</ArticleId><ArticleId IdType="pubmed">36674238</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher H., Chaftari A.-M., Subbiah I.M., Malek E.A., Jiang Y., Lamie P., Granwehr B., John T., Yepez E., Borjan J., et al. Long COVID in cancer patients: Preponderance of symptoms in majority of patients over long time period. eLife. 2023;12:e81182. doi: 10.7554/eLife.81182.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.81182</ArticleId><ArticleId IdType="pmc">PMC9977271</ArticleId><ArticleId IdType="pubmed">36748905</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Torres-Macho J., Guijarro C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero O.J., Plaza-Manzano G. Trajectory of Gastrointestinal Symptoms in Previously Hospitalized COVID-19 Survivors: The Long COVID Experience Multicenter Study. Viruses. 2023;15:1134. doi: 10.3390/v15051134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051134</ArticleId><ArticleId IdType="pmc">PMC10221203</ArticleId><ArticleId IdType="pubmed">37243220</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Zhang L., Elb&#xe9;ji A., Wilmes P., Oustric P., Staub T., Nazarov P.V., Ollert M., Fagherazzi G. Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infect. Dis. 2022;9:ofac397. doi: 10.1093/ofid/ofac397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Golla R., Vuyyuru S., Kante B., Kumar P., Thomas D.M., Makharia G., Kedia S., Ahuja V. Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study. Clin. Gastroenterol. Hepatol. 2023;21:789&#x2013;796. doi: 10.1016/j.cgh.2022.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2022.10.015</ArticleId><ArticleId IdType="pmc">PMC9584755</ArticleId><ArticleId IdType="pubmed">36273799</ArticleId></ArticleIdList></Reference><Reference><Citation>Imoto W., Yamada K., Kawai R., Imai T., Kawamoto K., Uji M., Kanda H., Takada M., Ohno Y., Ohtani H., et al. A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID. Sci. Rep. 2022;12:22413. doi: 10.1038/s41598-022-25398-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25398-6</ArticleId><ArticleId IdType="pmc">PMC9793373</ArticleId><ArticleId IdType="pubmed">36575200</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuna S., A Gallardo-Cartagena J., Theodore D., Hunidzarira P., Montenegro-Idrogo J., Hu J., Jones M., Kim V., De La Grecca R., Trahey M., et al. Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region. J. Glob. Health. 2023;13:06020. doi: 10.7189/jogh.13.06020.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.06020</ArticleId><ArticleId IdType="pmc">PMC10289480</ArticleId><ArticleId IdType="pubmed">37352144</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedik R.N.M. The clinical course and outcomes of SARS-CoV-2 virus infection in children: A 24-week follow-up study in Sulaimaniyah, Iraq. BMC Pediatr. 2023;23:303. doi: 10.1186/s12887-023-04111-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-023-04111-0</ArticleId><ArticleId IdType="pmc">PMC10276471</ArticleId><ArticleId IdType="pubmed">37330479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat. Commun. 2023;14:983. doi: 10.1038/s41467-023-36223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36223-7</ArticleId><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto R., Yamamoto A., Masaoka T., Homma K., Matsuoka T., Takemura R., Wada M., Sasaki J., Kanai T., Amagai M., et al. Early symptoms preceding post-infectious irritable bowel syndrome following COVID-19: A retrospective observational study incorporating daily gastrointestinal symptoms. BMC Gastroenterol. 2023;23:108. doi: 10.1186/s12876-023-02746-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-023-02746-y</ArticleId><ArticleId IdType="pmc">PMC10075174</ArticleId><ArticleId IdType="pubmed">37020263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Chen C., Xie Y., Zeng F., Chen S., Chen R., Zhang X., Huang S., Li D., Bai F. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A prospective follow-up cohort study. BMC Infect. Dis. 2023;23:422. doi: 10.1186/s12879-023-08401-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08401-x</ArticleId><ArticleId IdType="pmc">PMC10286442</ArticleId><ArticleId IdType="pubmed">37344782</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Chen T.Y.-T., Wang S.-I., Hung Y.-M., Chen H.-Y., Wei C.-C.J. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023;56:101783. doi: 10.1016/j.eclinm.2022.101783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao G.V., Gella V., Radhakrishna M., Kumar V.J., Chatterjee R., Kulkarni A., Reddy D.N. Post-COVID-19 symptoms are not uncommon among recovered patients-A cross-sectional online survey among the Indian population. MedRxiv. 2021 doi: 10.1101/2021.07.15.21260234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.15.21260234</ArticleId><ArticleId IdType="pmc">PMC9200210</ArticleId><ArticleId IdType="pubmed">35488693</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima G., Bhatt D., Idrees J., Khalid B., Mahdi F. Elucidating Post-COVID-19 manifestations in India. MedRxiv. 2021 doi: 10.1101/2021.07.06.21260115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.06.21260115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Zhang L., Wei R., Dai W., Zeng R., Luo D., Jiang R., Wu H., Zhuo A., Yang Q., et al. Risks of digestive diseases in long COVID: Evidence from a large-scale cohort study. MedRxiv. 2023 doi: 10.1101/2023.04.25.23289080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.25.23289080</ArticleId><ArticleId IdType="pmc">PMC10777515</ArticleId><ArticleId IdType="pubmed">38195495</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson N.W., Thiesson E.M., Lassauni&#xe8;re R., Hansen J.V., Hviid A. SARS-CoV-2 infection and post-acute risk of non-Covid-19 infectious disease hospitalizations: A nationwide cohort study of Danish adults aged &#x2265;50 years. MedRxiv. 2023 doi: 10.1101/2023.04.03.23288102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.03.23288102</ArticleId><ArticleId IdType="pubmed">37740392</ArticleId></ArticleIdList></Reference><Reference><Citation>Koloski N.A., Jones M., Hammer J., von Wulffen M., Shah A., Hoelz H., Kutyla M., Burger D., Martin N., Gurusamy S.R., et al. The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting. Dig. Dis. Sci. 2017;62:1913&#x2013;1922. doi: 10.1007/s10620-017-4599-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-017-4599-6</ArticleId><ArticleId IdType="pubmed">28551709</ArticleId></ArticleIdList></Reference><Reference><Citation>Daines L., Zheng B., Pfeffer P., Hurst J.R., Sheikh A. A clinical review of long-COVID with a focus on the respiratory system. Curr. Opin. Pulm. Med. 2022;28:174&#x2013;179. doi: 10.1097/MCP.0000000000000863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0000000000000863</ArticleId><ArticleId IdType="pmc">PMC7612723</ArticleId><ArticleId IdType="pubmed">35131989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Liu Y., Tang X., He D. The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern. Front. Public Health. 2021;9:775224. doi: 10.3389/fpubh.2021.775224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.775224</ArticleId><ArticleId IdType="pmc">PMC8669511</ArticleId><ArticleId IdType="pubmed">34917580</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleem A., Akbar Samad A.B., Vaqar S. Emerging Variants of SARS-CoV-2 and Novel Therapeutics against Coronavirus (COVID-19) StatPearls Publishing; Treasure Island, FL, USA: 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033342</ArticleId></ArticleIdList></Reference><Reference><Citation>Splinter M.J., Velek P., Ikram M.K., Kieboom B.C.T., Peeters R.P., Bindels P.J.E., Wolters F.J., Leening M.J.G., de Schepper E.I.T., Licher S. Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study. PLoS Med. 2021;18:e1003854. doi: 10.1371/journal.pmed.1003854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003854</ArticleId><ArticleId IdType="pmc">PMC8610236</ArticleId><ArticleId IdType="pubmed">34813591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani J., Madani S. Pediatric abdominal migraine: Current perspectives on a lesser known entity. Pediatr. Health Med. Ther. 2018;9:47&#x2013;58. doi: 10.2147/PHMT.S127210.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PHMT.S127210</ArticleId><ArticleId IdType="pmc">PMC5923275</ArticleId><ArticleId IdType="pubmed">29733088</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera N., Santesmasses D., Kerepesi C., Gladyshev V.N. COVID-19 mortality rate in children is U-shaped. Aging. 2021;13:19954&#x2013;19962. doi: 10.18632/aging.203442.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203442</ArticleId><ArticleId IdType="pmc">PMC8436910</ArticleId><ArticleId IdType="pubmed">34411000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Restrepo-Jim&#xe9;nez P., Monsalve D.M., Pacheco Y., Acosta-Ampudia Y., Ram&#xed;rez-Santana C., Leung P.S.C., Ansari A.A., Gershwin M.E., Anaya J.M. Molecular mimicry and autoimmunity. J. Autoimmun. 2018;95:100&#x2013;123. doi: 10.1016/j.jaut.2018.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.012</ArticleId><ArticleId IdType="pubmed">30509385</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata G., Petrosillo N., Al Moghazi S., Caraffa E., Puro V., Tillotson G., Cataldo M.A. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis. Anaerobe. 2022;74:102484. doi: 10.1016/j.anaerobe.2021.102484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2021.102484</ArticleId><ArticleId IdType="pmc">PMC8616765</ArticleId><ArticleId IdType="pubmed">34843959</ArticleId></ArticleIdList></Reference><Reference><Citation>Love N.K., Elliot A.J., Chalmers R.M., Douglas A., Gharbia S., McCormick J., Hughes H., Morbey R., Oliver I., Vivancos R., et al. Impact of the COVID-19 pandemic on gastrointestinal infection trends in England, February-July 2020. BMJ Open. 2022;12:e050469. doi: 10.1136/bmjopen-2021-050469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-050469</ArticleId><ArticleId IdType="pmc">PMC8968111</ArticleId><ArticleId IdType="pubmed">35314468</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Soucy J.-P.R., Westwood D., Daneman N., MacFadden D.R. Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis. Clin. Microbiol. Infect. 2021;27:520&#x2013;531. doi: 10.1016/j.cmi.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7785281</ArticleId><ArticleId IdType="pubmed">33418017</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani M.A., Alshamrani A.S., Ahmasani I.M., Alahmari F.S., Asiri A.H., Alshehri A.M., Alsamghan A.S., Awadalla N.J. Coronavirus disease 2019 pandemic stress and its effects on irritable bowel syndrome patients in Saudi Arabia. Medicine. 2020;99:e23711. doi: 10.1097/MD.0000000000023711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000023711</ArticleId><ArticleId IdType="pmc">PMC7748344</ArticleId><ArticleId IdType="pubmed">33371119</ArticleId></ArticleIdList></Reference><Reference><Citation>Peirce J.M., Alvi&#xf1;a K. The role of inflammation and the gut microbiome in depression and anxiety. J. Neurosci. Res. 2019;97:1223&#x2013;1241. doi: 10.1002/jnr.24476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24476</ArticleId><ArticleId IdType="pubmed">31144383</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M.C.-S., Huang J., Wong Y.-Y., Wong G.L.-H., Yip T.C.-F., Chan R.N.-Y., Chau S.W.-H., Ng S.-C., Wing Y.-K., Chan F.K.-L. Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study. JMIR Public Health Surveill. 2023;9:e42315. doi: 10.2196/42315.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/42315</ArticleId><ArticleId IdType="pmc">PMC9994465</ArticleId><ArticleId IdType="pubmed">36645453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>